Mike Powell

Managing General Partner at Sofinnova Investments, Inc.

Mike Powell

Mike Powell

Managing General Partner at Sofinnova Investments, Inc.

Overview
Career Highlights

Sofinnova Investments, Inc.
Supply Vision, Inc.

RelSci Relationships

3409

Number of Boards

40

Birthday

1955

Age

66

Contact Data
Trying to get in touch with Mike Powell? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Mike Powell likely has professional access to. A relationship does not necessarily indicate a personal connection.

President, Chief Executive Officer & Director at Dauntless Pharmaceuticals, Inc.

Relationship likelihood: Strong

Managing Partner at Sofinnova Investments, Inc.

Relationship likelihood: Strong

Chairman at Ascenta Therapeutics, Inc.

Relationship likelihood: Strong

Executive Partner, Private Equity at Sofinnova Investments, Inc.

Relationship likelihood: Strong

Founder at Checkmate Pharmaceuticals, Inc.

Relationship likelihood: Strong

General Partner at Canaan Management, Inc.

Relationship likelihood: Strong

Executive Partner, Private Equity at Sofinnova Investments, Inc.

Relationship likelihood: Strong

Founding Partner at Sofinnova Investments, Inc.

Relationship likelihood: Strong

Partner & Chief Financial Officer at Sofinnova Investments, Inc.

Relationship likelihood: Strong

Vice Chancellor of Innovation & Partnerships at University of California - San Francisco

Relationship likelihood: Strong

Paths to Mike Powell
Potential Connections via
Relationship Science
You
Mike Powell
Managing General Partner at Sofinnova Investments, Inc.
Education
PhD in Physical Chemistry
Class of 1981

Established in 1827, the University of Toronto has one of the strongest research and teaching faculties in North America, presenting top students at all levels with an intellectual environment unmatched in depth and breadth on any other Canadian campus. With more than 82,000* students across three campuses (St. George, Mississauga and Scarborough) and over 500,000 alumni active in every region of the world, U of T's influence is felt in every area of human endeavour.

Memberships
Fellow
Current

American Association of Pharmaceutical Scientists is a private company headquartered in Arlington, VA, that engages in research and development of pharmaceutical products. The firm was founded by Leslie Z. Benet.The company says this about itself: The American Association of Pharmaceutical Scientists (AAPS) is a professional scientific organization of approximately 9,000 members employed in academia, industry, government, and other research institutes worldwide. Founded in 1986, AAPS advances the capacity of pharmaceutical scientists to develop products and therapies that improve global health.

Career History
Managing General Partner
1997 - Current

Sofinnova Investment Inc. invests in companies located in the US and Europe. The firm targets companies operating in the fields of health technology services and life science and has primarily focused on therapeutic drugs. It provides financing for early and later stage capital requirements with investment size ranges from $15 to $35 million. It invests in both private & public companies.

General Partner
Current

Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod (CMP-001), is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.

Investor
Current

InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA.

Boards & Committees
Director
Prior

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Director
Prior

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.

Political Donations
$1,000
2012

Former President of United States

$2,000
2008

Former Senator from New York

$500
2003

Former Governor of South Carolina

Transactions
Details Hidden

Ascenta Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

SOFINNOVA VENTURE PARTNERS IX, L.P. raised money in a private placement transaction

Investments
Details Hidden

Veridium US LLC provides end-to-end biometric authentication designed to safeguard enterprises. Its solutions help organizations to increase security, reduce fraud, and cut the costs associated with passwords and traditional multi-factor authentication solutions. The firm offers VeridiumID, VeridiumAD and 4 Fingers TouchlessID solutions. The company was founded by Hector Hoyos in 2005 and is headquartered in New York, NY.

Details Hidden

Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA.

Details Hidden

Sofinnova Investment Inc. invests in companies located in the US and Europe. The firm targets companies operating in the fields of health technology services and life science and has primarily focused on therapeutic drugs. It provides financing for early and later stage capital requirements with investment size ranges from $15 to $35 million. It invests in both private & public companies.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mike Powell. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mike Powell's profile does not indicate a business or promotional relationship of any kind between RelSci and Mike Powell.